Amendment SA12-AB100

LRBb0782/1

RLR:wlj&lmk:jf

2005 - 2006 LEGISLATURE

SENATE AMENDMENT 12, TO 2005 ASSEMBLY BILL 100

June 29, 2005 - Offered by Senator Miller.

AB100-SA12,1,1 At the locations indicated, amend the engrossed bill as follows:

AB100-SA12,1,2 1. Page 798, line 2: after that line insert:

AB100-SA12,1,3 " Section 2026m. 146.347 of the statutes is created to read:

AB100-SA12,1,5 146.347 Stem cells and embryos. (1) In this section, "health care provider" has the meaning given in s. 150.84 (3).

AB100-SA12,1,7 (2) A person may conduct research involving the derivation of human embryonic stem cells if all of the following conditions are satisfied:

AB100-SA12,1,9 (a) The research is approved by an institutional review board acting in accordance with the provisions under 21 CFR part 56.

AB100-SA12,1,13 (b) The research is approved by an Embryonic Stem Cell Research Oversight Committee that is established and operates in accordance with guidelines developed jointly by the National Academies' National Research Council and Institute of Medicine.

AB100-SA12,2,5 (3) (a) A health care provider who treats a patient for infertility shall provide the patient information on options for disposing of any human embryos remaining at the completion of the treatment, including information regarding storing embryos, donating embryos to another individual, or donating embryos for research purposes.

AB100-SA12,2,9 (b) A health care provider or other person in possession of human embryos used for treatment of infertility may not use or release the embryos for research purposes unless the donor of the embryos provides written consent for using the embryos for research purposes.".

AB100-SA12,2,10 (End)